CD4 and neoplasm: By stimulating NK cells, CD8+ T cells, and other innate immune cells, CD4+ T cells can inhibit tumor progression [43], and cytokines produced by CD4+ T cells upon contact with tumor cell surface antigens can stimulate the production and activation of CD8+ T cells [44].